IL-2 + anti-CD16 mAbs-treated ALS patients’ NK cells mediated significantly increased cytotoxicity whereas a slight change in cytotoxicity level was seen in IL-2-treated NK cells (Figure 2a,b). This evidence concerns the gene IL2 and amyotrophic lateral sclerosis.